Saffron for Mood: What Research Shows and How to Spot Fakes

Saffron (Crocus sativus) is a culinary spice derived from the dried stigmas of the crocus flower, standardised in supplement form to its active compounds safranal and crocin, the constituents most studied for mood effects. Most botanicals sold for mood rest on thin evidence: a handful of small studies, a plausible-sounding mechanism, and a lot of optimism. Saffron is the exception. The dried stigmas of the Crocus sativus flower have been through more controlled human trials for low mood than almost any other supplement on this site, and the results are genuinely interesting.

But saffron comes with a second, less flattering distinction: it is one of the most counterfeited foods on earth. The same scarcity that makes “red gold” expensive also makes it worth faking, and a meaningful share of what’s sold as saffron isn’t saffron at all. This post covers two things: what the research honestly supports, and how to tell a real, properly dosed extract from an underdosed or adulterated one.

A note before we start: everything below is about supporting mood, stress, and sleep. Saffron is not a treatment for depression or any diagnosed condition, and nothing here is medical advice. If you’re struggling, the most useful first step is a conversation with a clinician. See our crisis and professional-support resources.

What saffron is, and why it’s studied for mood

Saffron is harvested by hand from the three crimson stigmas inside each Crocus sativus flower. It takes roughly 150 flowers for a single gram, which is why it’s the most expensive spice by weight in the world. Its activity is usually attributed to a few compounds: crocins (the carotenoid pigments behind its colour), safranal (the aromatic compound), and crocetin, the metabolite that actually shows up in the bloodstream after you absorb crocins.

The proposed mechanisms are familiar: effects on serotonin signalling, antioxidant and anti-inflammatory activity, and modulation of the stress (HPA-axis) response. These are reasonable hypotheses supported by laboratory work, but the human mechanism is not nailed down. One well-controlled trial found that rising urinary crocetin tracked with improvement in depression scores, which is a hint that the absorbed compound is doing something, but a hint is not proof.

What the research actually shows

Compared to placebo

This is saffron’s strongest card. A 2019 systematic review and meta-analysis of 23 randomized trials found a large positive effect on depressive symptoms versus placebo (Hedges’ g ≈ 0.99) and a similarly large effect on anxiety symptoms. A separate 2019 meta-analysis reached a consistent conclusion, reporting saffron as significantly more effective than placebo for mild-to-moderate depression.

Effect sizes that large are unusual for a supplement, and they’re the reason saffron gets taken seriously. But the same 2019 review also flagged two problems: evidence of publication bias (smaller, less favourable studies may be missing from the literature) and a lack of regional diversity (a large share of the trials come from a small number of research groups in one country). Both tend to inflate apparent effects, so the true number is probably more modest than g ≈ 0.99.

Compared to, and alongside, antidepressants

Several head-to-head trials in people with mild-to-moderate depression have compared standardized saffron to SSRIs such as fluoxetine and citalopram, generally finding comparable symptom improvement with fewer reported side effects. A 2025 meta-analysis in Nutrition Reviews pooled eight of these trials and found no statistically significant difference between saffron and SSRIs for depressive symptoms, with fewer adverse events in the saffron groups. A 2019 trial also tested saffron as an add-on to existing antidepressant medication and reported a benefit on persistent symptoms.

That is a striking result for a botanical, but please read the caveats carefully, because this is exactly the kind of finding that gets oversold. These trials were short (typically six to twelve weeks), enrolled people with mild-to-moderate symptoms (not severe depression), and “fewer side effects than an SSRI” is a low bar rather than evidence of a powerful effect. None of this makes saffron a substitute for professional care, and it is emphatically not a reason to start, stop, or change prescribed medication on your own. If you take an antidepressant, the adjunct trials were done under supervision. See the cautions section below before combining anything.

The affron® trials specifically

Much of the modern evidence centres on a single standardized extract, affron®, dosed at 28 mg/day. A 2017 trial in healthy adults found a meaningful reduction in total mood disturbance over four weeks at that dose. A 2018 study extended the finding to teenagers with anxiety and depressive symptoms, and in 2025 the largest saffron mood trial to date (202 adults with subclinical low mood, supplemented for 12 weeks) reported improvements in mood and stress emerging by around week five. A second branded extract, Safr’Inside™, has its own placebo-controlled trial in healthy adults with low mood and stress.

The consistency is reassuring, but most of these affron® trials were conducted by an overlapping group of researchers, and the extract is a commercial product whose manufacturer has an interest in positive results. That doesn’t make the findings wrong (the 2025 trial was large and well-designed), but it does mean the evidence base is narrower than the raw study count suggests. Not every trial is positive, either: at least one affron® study in recreationally active adults found no significant benefit on its outcomes.

On our evidence scale, saffron sits at Moderate, one of the stronger Moderates on this site and just short of “Well-studied.” Multiple meta-analyses, large placebo effect sizes, and a robust recent RCT pull it up; publication bias, regional concentration, short durations, and commercial funding ties keep it from the top tier. We’d rather under-claim than overstate it.

How much, and how long until it works

Across the mood research, the studied dose is remarkably consistent: roughly 28–30 mg per day of a standardized extract, frequently split into a morning and evening dose. More is not obviously better. The trials that work, work at this modest dose, and there’s no good reason to chase higher amounts.

On timing, set expectations for weeks rather than days. Most trials measured benefits at the four-to-six-week mark, with some signal as early as week five in the largest study. Saffron is a “take it consistently and reassess in a month” supplement, not a same-day mood lift. If you’ve given a real, properly dosed extract six to eight weeks of consistent use and notice nothing, it’s reasonable to stop.

How to buy saffron that isn’t fake or quietly underdosed

Saffron’s price creates a powerful incentive to cut or counterfeit it, and the scale of the problem is well documented: in one study that used DNA barcoding to test 104 market samples from 16 countries, about 43% were adulterated. Common tricks include substituting safflower or Gardenia petals, padding threads with dyed corn silk or other plant fibres, and adding synthetic colourants to fake the rich red. The international quality standard, ISO 3632, exists precisely because this fraud is so routine.

For a supplement, you mostly can’t eyeball any of this. It’s a powder in a capsule, so the safeguards are different from the kitchen tests you’ll see for loose threads. When you choose the standardized saffron extract we profile, or any competitor, this is the checklist that actually protects you:

1. The two extracts with real human-trial backing are affron® (standardized to ≥3.5% Lepticrosalides) and Safr’Inside™. A label that just says “saffron extract” with no named source and no trials behind it is a red flag: it asks you to trust the marketing, not the research.
2. Look for 28–30 mg of the standardized extract. Be wary of “proprietary blends” that hide saffron below the trial dose, and equally wary of mega-dose products implying more is better.
3. The label should specify the actives (crocins/safranal, or the branded marker Lepticrosalides for affron®), not just a raw milligram weight of unspecified “saffron.”
4. Given the 43%-adulteration backdrop, independent verification (ISO 3632 / HPLC, or a published COA) is the single best defence against safflower, Gardenia, and synthetic dyes ending up in your capsule.
5. Reputable products state where the saffron comes from and use stigma extract rather than undisclosed plant parts.

In short, the buying criterion for saffron is simpler than it looks: a named, standardized, trial-backed extract at the studied dose, verifiable against adulteration. Everything else is decoration.

Cautions and who should be careful

Saffron is well tolerated at supplement doses. The adverse events in trials are usually mild (some nausea, headache, or drowsiness), and toxicity only appears at gram-level doses far above anything in a capsule. But “well tolerated” is not the same as “fine for everyone,” and a few situations genuinely matter.

Pregnancy is the clearest concern: saffron can act as a uterine stimulant at higher doses and has a historical reputation as an abortifacient. Standardized supplements should not be used in pregnancy; even culinary amounts warrant a conversation with your obstetric provider.

If you take an antidepressant, talk to your prescriber before adding saffron. Saffron has serotonin-related activity, so combining it with SSRIs, SNRIs, or MAOIs carries a theoretical risk of excess serotonergic effects. The adjunct trials that combined them were medically supervised. This is not something to stack on your own. The same caution applies to other mood supplements; see our note on 5-HTP and serotonin safety.

For bipolar disorder, use saffron only under the guidance of a clinician managing your condition, given its mood-elevating activity.

Saffron may have mild blood-thinning effects, so coordinate with your doctor if you take warfarin or similar medication, and pause before scheduled surgery.

Stop and seek care if you notice rash, breathing difficulty, or other allergic symptoms.

Where saffron fits

If you have mild, situational low mood or stress and want an evidence-aware botanical to support the basics, saffron is one of the more defensible choices available. The research is real, the dose is modest, and the safety profile at that dose is good. It works best as one piece of a broader foundation of sleep, movement, daylight, and connection, not as a substitute for those.

Our overview of the lifestyle foundations of mood support is the right place to start.

Supporting your mood is not the same as treating an illness. If your low mood is persistent, worsening, or interfering with daily life, that’s a sign to involve a professional rather than reach for a supplement. Our get-help page lists where to turn.

---

This article is for general information and mood support only. It is not medical advice and does not diagnose, treat, or cure any condition. Read our full medical disclaimer, and speak with a qualified healthcare professional before starting any supplement, especially if you are pregnant, taking medication, or managing a health condition.

Sources

1. Tóth B, Hegyi P, Lantos T, et al. The Efficacy of Saffron in the Treatment of Mild to Moderate Depression: A Meta-analysis. Planta Med. 2019;85(1):24–31. PMID: 30036891. https://pubmed.ncbi.nlm.nih.gov/30036891/
2. Marx W, Lane M, Rocks T, et al. Effect of saffron supplementation on symptoms of depression and anxiety: a systematic review and meta-analysis. Nutr Rev. 2019;77(8):557–571. PMID: 31135916. https://pubmed.ncbi.nlm.nih.gov/31135916/
3. Effect of saffron versus selective serotonin reuptake inhibitors (SSRIs) in treatment of depression and anxiety: a meta-analysis of randomized controlled trials. Nutr Rev. 2025;83(3):e751–e764. PMID: 38913392. https://pubmed.ncbi.nlm.nih.gov/38913392/
4. Kell G, Rao A, Beccaria G, et al. affron® a novel saffron extract (Crocus sativus L.) improves mood in healthy adults over 4 weeks in a double-blind, parallel, randomized, placebo-controlled clinical trial. Complement Ther Med. 2017;33:58–64. doi:10.1016/j.ctim.2017.06.001. https://doi.org/10.1016/j.ctim.2017.06.001
5. Lopresti AL, Smith SJ, Marx W, Díez-Municio M, Morán-Valero MI. An Examination into the Effects of a Saffron Extract (Affron) on Mood and General Wellbeing in Adults Experiencing Low Mood: A Randomized, Double-Blind, Placebo-Controlled Trial. J Nutr. 2025;155(7):2300–2311. doi:10.1016/j.tjnut.2025.05.024. https://doi.org/10.1016/j.tjnut.2025.05.024
6. Lopresti AL, Smith SJ, Hood SD, Drummond PD. Efficacy of a standardised saffron extract (affron®) as an add-on to antidepressant medication for the treatment of persistent depressive symptoms in adults: A randomised, double-blind, placebo-controlled study. J Psychopharmacol. 2019;33(11):1415–1427. PMID: 31423933. https://pubmed.ncbi.nlm.nih.gov/31423933/
7. Lopresti AL, Drummond PD, Inarejos-García AM, et al. affron®, a standardised extract from saffron (Crocus sativus L.) for the treatment of youth anxiety and depressive symptoms: A randomised, double-blind, placebo-controlled study. J Affect Disord. 2018;232:349–357. PMID: 29510863. https://pubmed.ncbi.nlm.nih.gov/29510863/
8. Identification of adulteration in the market samples of saffron using morphology, HPLC, HPTLC, and DNA barcoding methods. Genome. 2022. doi:10.1139/gen-2022-0059. https://cdnsciencepub.com/doi/10.1139/gen-2022-0059